The cost-effectiveness of direct-to-consumer advertising for prescription drugs.
Med Care Res Rev
; 66(6): 639-57, 2009 Dec.
Article
en En
| MEDLINE
| ID: mdl-19423875
ABSTRACT
In this paper we use published information to analyze the economic value of Direct to Consumer Advertising (DTCA). The reviewed research finds that DTCA leads to increased demand for the advertised drug and that the effect of the drug tends to be class-wide rather than product specific. There is weak evidence that DTCA may increase compliance and improve clinical outcomes. However, there is little research on the effect of DTCA on inappropriate prescribing or on the characteristics of patients who respond to treatment. On net, if the advertised drugs are cost effective on average and the patients using the drugs in response to the advertisement are similar to other users, DTCA is likely cost effective. Overall, the literature to date is consistent with the idea that DTCA is beneficial, but further research is needed before definitive conclusions can be drawn.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Costos de la Atención en Salud
/
Publicidad
/
Medicamentos bajo Prescripción
Tipo de estudio:
Health_economic_evaluation
Límite:
Humans
Idioma:
En
Revista:
Med Care Res Rev
Asunto de la revista:
PESQUISA EM SERVICOS DE SAUDE
Año:
2009
Tipo del documento:
Article
País de afiliación:
Estados Unidos